Literature DB >> 10627307

Activation of mouse microglial cells affects P2 receptor signaling.

T Möller1, O Kann, A Verkhratsky, H Kettenmann.   

Abstract

Microglial cells are the immunocompetent cells of the CNS, which are known to exist in several activation states. Here we investigated the impact of microglial activation on the P2 receptor-mediated intracellular calcium ([Ca(2+)](i)) signaling by means of fluo-3 based Ca(2+)-imaging. Cultured mouse microglial cells were treated with either astrocyte-conditioned medium to induce a ramified morphology or LPS to shift the cells toward the fully activated stage. The extracellular application of ATP (100 microM) induced a [Ca(2+)](i) elevation in 85% of both untreated and ramified microglial cells, whereas only 50% of the LPS-activated cells responded to the stimulus. To characterise the pharmacological profile of microglial P2 receptors we investigated the effects of various P2 agonists on [Ca(2+)](i) in cultured microglial cells. Untreated and ramified microglial cells demonstrated a very similar sensitivity to the different P2 agonists. In contrast, in LPS-activated microglia, a sharp decrease of responses to P2 agonist stimulation was seen. This indicates that microglial activation influences the capability of microglial cells to generate [Ca(2+)](i) signals upon P2 receptor activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10627307     DOI: 10.1016/s0006-8993(99)02244-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  30 in total

Review 1.  Purinoceptors in microglia and neuropathic pain.

Authors:  Tuan Trang; Simon Beggs; Michael W Salter
Journal:  Pflugers Arch       Date:  2006-04-22       Impact factor: 3.657

Review 2.  Purinergic signaling and microglia.

Authors:  Katrin Färber; Helmut Kettenmann
Journal:  Pflugers Arch       Date:  2006-06-21       Impact factor: 3.657

3.  Purinergic receptors activating rapid intracellular Ca increases in microglia.

Authors:  Alan R Light; Ying Wu; Ronald W Hughen; Peter B Guthrie
Journal:  Neuron Glia Biol       Date:  2006-05

Review 4.  Purinergic transmission in the central nervous system.

Authors:  R Alan North; Alexei Verkhratsky
Journal:  Pflugers Arch       Date:  2006-05-11       Impact factor: 3.657

Review 5.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

Review 6.  Microglia biology in health and disease.

Authors:  Gwenn A Garden; Thomas Möller
Journal:  J Neuroimmune Pharmacol       Date:  2006-03-25       Impact factor: 4.147

Review 7.  Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Authors:  Marie Therese Armentero; Annalisa Pinna; Sergi Ferré; José Luis Lanciego; Christa E Müller; Rafael Franco
Journal:  Pharmacol Ther       Date:  2011-07-23       Impact factor: 12.310

8.  Purinergic junctional transmission and propagation of calcium waves in cultured spinal cord microglial networks.

Authors:  Max R Bennett; Vlado Buljan; Les Farnell; William G Gibson
Journal:  Purinergic Signal       Date:  2007-10-23       Impact factor: 3.765

9.  Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease.

Authors:  Ana María Martín-Moreno; David Reigada; Belén G Ramírez; R Mechoulam; Nadia Innamorato; Antonio Cuadrado; María L de Ceballos
Journal:  Mol Pharmacol       Date:  2011-02-24       Impact factor: 4.436

10.  Transient changes in the localization and activity of ecto-nucleotidases in rat hippocampus following lipopolysaccharide treatment.

Authors:  Agnes Kittel; Beata Sperlágh; Julie Pelletier; Jean Sévigny; Terence L Kirley
Journal:  Int J Dev Neurosci       Date:  2007-05-17       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.